The infrastructure a trial needs, without a practice having to build it.
Fairmont Clinical partners with independent physician practices across the Southeast to run pharmaceutical and biotech clinical trials — handling feasibility, regulatory start-up, patient recruitment, and data management so the practice can focus on patients, not paperwork.
We sit in the middle so the practice never has to build this infrastructure themselves.
Trials default to academic centers. Community practices often have the better patient population.
Sponsors gravitate toward large academic medical centers because they already have research infrastructure in place — not necessarily because they have the right patients. Independent community practices frequently serve more diverse populations, which sponsors increasingly need and regulators increasingly expect, but lack the regulatory and operational scaffolding to participate. That gap is the entire reason Fairmont Clinical exists.
Feasibility, regulatory start-up, recruitment, and data — handled at the site.
Four services, all delivered at the physical location where the trial actually happens.
Dr. Adanna Osei kept watching good practices get passed over.
As a practicing internist, she saw sponsors repeatedly choose academic centers for trials her own patients would have qualified for and wanted access to — not because the science required it, but because her practice had nowhere to start. Fairmont Clinical exists to be that starting point.
Six stages, from feasibility to close-out.
Every trial we support at a site moves through the same lifecycle, whether it enrolls five patients or two hundred.
Considering clinical trials for your practice, or a sponsor looking for sites with genuinely diverse patient access? Get in touch — most conversations start with a feasibility conversation, not a contract.